Innovating Organoid Technologies to Recapitulate Complex CNS Immune Cell Interactions & Bolster Neuroinflammatory Target Discovery

  • How organoid models are used to simulate the BBB and enable small molecule screening for CNS drug candidates
  • Addressing challenges in organoid maturity, reproducibility, and relevance to human disease biology
  • The importance of incorporating multiple CNS cell types, including microglia and astrocytes, for inflammation studies
  • Comparing organoid approaches with traditional animal and cell-based models in neuroinflammation research
  • Emerging efforts to harmonize organoid protocols and enhance translatability to clinical settings